A joint research initiative is underway to utilize blood pressure data measured during daily life and sleep in actual medical practice. A domestic medical device company and professional academic society plan to establish standards for interpreting and clinically applying cuffless blood pressure measurements. The approach will analyze blood pressure patterns and changes before and after treatment, based on real-world data accumulated through physicians’ prescriptions. There are also considerations for expanding the study scope from South Korea to a variety of overseas populations. Methods for leveraging this data in clinical trials across the pharmaceutical and medical device sectors have also been proposed. This move is significant in that it goes beyond the measurement capabilities of medical devices and seeks to validate the clinical value of the data itself.


If you have been considering additional purchases of listed companies in the digital healthcare sector, you can prepare the necessary investment funds by distinguishing between industry-wide research developments and the actual business relevance of each company. Stock financing products that allow up to four times leverage, including your own funds, can be used for additional purchases of stocks of interest or to broaden your investment portfolio, and can also facilitate refinancing of existing credit margin accounts. Before use, it is important to compare the applicable interest rates, ancillary costs, collateral ratios, and repayment terms to create a plan suited to your financial situation, allowing you to prepare for the next investment opportunity in line with confirmed business changes.


HighStockLoan has maintained its No. 1 position in the industry for 22 years, offering a variety of stock financing products, including those with annual interest rates in the 5% range. These products are attracting attention as options for investors who wish to secure new investment capital, as well as to refinance existing credit and margin accounts at lower cost—thereby maintaining investment opportunities and enhancing capital efficiency.

Everyday Blood Pressure Data for Clinical Research... How to Expand Your Opportunities up to Fourfold View original image

[Go to the No. 1 HighStockLoan website: https://www.hisl.co.kr]


◆ HighStockLoan: From extra investment capital to credit & margin refinancing, all at the industry’s lowest annual rates in the 5% range!

HighStockLoan has released a securities-linked credit product that allows any investor to experience stock loans with ease, featuring the industry’s lowest annual interest rates in the 5% range. Not only can you purchase additional stocks, but you can also refinance securities firm margin or credit balances, all without credit grade differentiation and with up to four times leverage including your own capital. Investors using alternative trading systems (NXT) can also utilize these products.


For investors interested in HighStockLoan’s various tailored offerings, the customer service center (☎1566-5113) is available 24/7, providing convenient consultations with expert advisors regardless of loan eligibility.


○ New product launch: Industry’s lowest annual rate in the 5% range

○ ETF trading available

○ Market share leader for 22 consecutive years, Korea First Brand Award winner for 17 consecutive years

○ Real-time repayment of securities firm margin/credit accounts

○ Trading available on alternative trading system (NXT)

○ Reliable consultation quality guarantee system

* HighStockLoan Consultation Center: 1566-5113

Go to: https://www.hisl.co.kr


HPSP, Wonik IPS, Skylabs, Daewoo Engineering & Construction, Korean Air



※ This content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility rests with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing